Anika Therapeutics, Inc. Annual Net Income (Loss) Attributable to Parent in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Anika Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2010 to 2023.
  • Anika Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$29.9M, a 355% decline year-over-year.
  • Anika Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$97.5M, a 297% decline year-over-year.
  • Anika Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$82.7M, a 456% decline from 2022.
  • Anika Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$14.9M, a 459% decline from 2021.
  • Anika Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was $4.13M.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$82.7M -$67.8M -456% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-15
2022 -$14.9M -$19M -459% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-15
2021 $4.13M +$28.1M Jan 1, 2021 Dec 31, 2021 10-K 2024-03-15
2020 -$24M -$51.2M -188% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-16
2019 $27.2M +$8.47M +45.2% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-11
2018 $18.7M -$13.1M -41.2% Jan 1, 2018 Dec 31, 2018 10-K/A 2021-04-26
2017 $31.8M -$731K -2.25% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-06
2016 $32.5M +$1.79M +5.82% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-27
2015 $30.8M -$7.56M -19.7% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-27
2014 $38.3M +$17.7M +86.2% Jan 1, 2014 Dec 31, 2014 10-K 2017-02-24
2013 $20.6M +$8.82M +75% Jan 1, 2013 Dec 31, 2013 10-K 2016-03-10
2012 $11.8M +$3.29M +38.9% Jan 1, 2012 Dec 31, 2012 10-K 2015-03-13
2011 $8.47M +$4.15M +96.2% Jan 1, 2011 Dec 31, 2011 10-K 2014-03-13
2010 $4.32M Jan 1, 2010 Dec 31, 2010 10-K 2013-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.